Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Beginning Cash Balance: 2016-2025

Historic Beginning Cash Balance for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $73.1 million.

  • Organogenesis Holdings' Beginning Cash Balance fell 18.67% to $73.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.3 million, marking a year-over-year decrease of 4.01%. This contributed to the annual value of $103.8 million for FY2024, which is 0.94% up from last year.
  • Organogenesis Holdings' Beginning Cash Balance amounted to $73.1 million in Q3 2025, which was down 33.46% from $109.9 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Beginning Cash Balance peaked at $135.6 million during Q1 2025, and registered a low of -$12.4 million during Q3 2021.
  • In the last 3 years, Organogenesis Holdings' Beginning Cash Balance had a median value of $94.3 million in 2024 and averaged $97.6 million.
  • Per our database at Business Quant, Organogenesis Holdings' Beginning Cash Balance plummeted by 421.02% in 2021 and then skyrocketed by 1,563.60% in 2022.
  • Organogenesis Holdings' Beginning Cash Balance (Quarterly) stood at $102.1 million in 2021, then increased by 4.98% to $107.2 million in 2022, then decreased by 8.28% to $98.3 million in 2023, then decreased by 4.05% to $94.3 million in 2024, then fell by 18.67% to $73.1 million in 2025.
  • Its Beginning Cash Balance was $73.1 million in Q3 2025, compared to $109.9 million in Q2 2025 and $135.6 million in Q1 2025.